Effectiveness of combination of pharmachothrapy with metacognitive therapy versus pharmachotherapy in patient with posttraumatic stress disorder

Not Applicable

Conditions: Post-traumatic stress disorder.
Post-traumatic stress disorder

Registration Number: IRCT2017060828504N2

Lead Sponsor: Vice chancellor for research of Iran University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Male

Target Recruitment: 6

Inclusion Criteria

Having a chronic PTSD based on DSM-4 criterias? Do not receive psychological treatment before the study? In the case of using medicine, the possibility of keeping the type and dose of drugs during the study? Minimum 18 years and maximum 50 years? with at least third level education? The patient agreed to participate in the study and signed a written consent.
Exclusion criteria: having a psychotic disorder and substance use disorder? Having full criteria for personality disorder in Axis II? There are risks for the patient such as having serious thoughts of suicide.

Exclusion Criteria

Not provided

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Subjective unit of distress. Timepoint: Pre test, Post test, Follow up ( 1month), Follow up ( 2 month). Method of measurement: Subjective unit of distress scale.;Anxiety. Timepoint: Pre test, Post test, Follow up ( 1 month) , Follow up ( 2 month). Method of measurement: Beck anxiety inventory.;PTSD Signs. Timepoint: Pre test, Post test, Follow up ( 1 month) , Follow up ( 2 month). Method of measurement: PTSD Inventory.;Depression. Timepoint: Pre test, Post test, Follow up(1 month), Follow up( month). Method of measurement: Beck depression inventory.;Metacognition. Timepoint: Pre test, Post test, Follow up(1 month), Follow up(2 month). Method of measurement: Metacognition Questionnaire-30 (MCQ-30).;General functioning. Timepoint: Pre test, Post test, Follow up ( 1 month),Follow up (2 month). Method of measurement: General assessment of functioning.

Secondary Outcome Measures